[JPI Seminar] Ministry of Health, Labour and Welfare: "Building a Drug Discovery Ecosystem and Measures to Promote Clinical Trials," to be held on Thursday, April 9

JPI (Japan Planning Institute) has invited Mr. Yasuhiro Araki, Director of the Clinical Trial Promotion Office, Research and Development Policy Division, Health Policy Bureau, Ministry of Health, Labour and Welfare, to hold a seminar providing a detailed explanation of measures to build a drug discovery ecosystem and promote clinical trials.

**Seminar Details:** - **Title:** The Worsening 'Drug Loss' Issue and Strengthening Japan's Drug Discovery Capabilities — MHLW: Building a Drug Discovery Ecosystem and Measures to Promote Clinical Trials: Regulatory Harmonization and Specific Measures for Rapid Delivery of Latest Pharmaceuticals. - **Date & Time:** Thursday, April 9, 2026, 09:30 - 11:30 (Archive distribution available after the event). - **Speaker:** Yasuhiro Araki, Director, Clinical Trial Promotion Office, MHLW. - **Lecture Overview:** In recent years, the 'drug loss' problem—where drugs approved in the West are not developed in Japan—has become apparent. To address this, the public and private sectors are working together to strengthen Japan's drug discovery power, deliver the latest medicines quickly, and build a sustainable social system for investment and innovation. This lecture will provide an overview of government efforts toward building a drug discovery ecosystem and detail the current state and promotional measures for clinical trials. - **Key Topics:** 1. Current status of drug loss in Japan. 2. Policies for building a drug discovery ecosystem. 3. Challenges in Japanese clinical trials. 4. MHLW initiatives to promote clinical trials. 5. Q&A and Networking.